|
CKAP2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.847800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.311600E-01 |
| Normal-vs-Stage2 |
1.367030E-01 |
| Normal-vs-Stage3 |
1.861780E-02 |
| Normal-vs-Stage4 |
7.229600E-02 |
| Stage1-vs-Stage2 |
5.185600E-02 |
| Stage1-vs-Stage3 |
1.393730E-02 |
| Stage1-vs-Stage4 |
6.254400E-02 |
| Stage2-vs-Stage3 |
2.773600E-01 |
| Stage2-vs-Stage4 |
2.540400E-01 |
| Stage3-vs-Stage4 |
8.718800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.031200E-01 |
| Normal-vs-AfricanAmerican |
4.564400E-02 |
| Normal-vs-Asian |
6.708300E-02 |
| Caucasian-vs-AfricanAmerican |
1.658360E-01 |
| Caucasian-vs-Asian |
5.637000E-01 |
| AfricanAmerican-vs-Asian |
9.406600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.426400E-01 |
| Normal-vs-Female |
1.076920E-03 |
| Male-vs-Female |
2.982600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.478600E-01 |
| Normal-vs-Extreme_Weight |
1.564250E-01 |
| Normal-vs-Obese |
5.399700E-02 |
| Normal-vs-Extreme_Obese |
8.210000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.192000E-02 |
| Normal_Weight-vs-Obese |
5.614200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.467800E-01 |
| Extreme_Weight-vs-Obese |
4.000000E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.581000E-01 |
| Obese-vs-Extreme_Obese |
4.767600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.905800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.317970E-02 |
| Normal-vs-Age(61-80Yrs) |
6.395200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.946410E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.978600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.077560E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.787980E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.219600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.338180E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.804760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.660570E-01 |
| Normal-VS-Type2 PRCC |
2.471500E-02 |
| Normal-VS-KIRP CIMP |
6.941900E-03 |
| Normal-VS-Unclassified PRCC |
1.006070E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.477400E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.623100E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.738080E-03 |
| Type2 PRCC-VS-KIRP CIMP |
9.234300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.287000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.615240E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.844000E-01 |
| Normal-vs-N1 |
9.035300E-04 |
| Normal-vs-N2 |
8.925400E-01 |
| N0-vs-N1 |
1.995600E-03 |
| N0-vs-N2 |
9.372800E-01 |
| N1-vs-N2 |
1.565160E-01 |
|
|
